Cite
HARVARD Citation
Govindaraj, C. et al. (n.d.). Lenalidomide‐based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients. American journal of hematology. 89 (8), pp. 795-802. [Online].